UBS analyst Steven Fisher raised the firm’s price target on Primoris to $63 from $44 and keeps a Buy rating on the shares. The company’s 2026 targets focus on execution, improving margins, and cash flow generation, the analyst tells investors in a research note.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on PRIM:
